ZYUS Life Sciences Corporation
ZYUS.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.76M | -15.53M | -2.87M | -3.52M | -2.48M |
| Total Depreciation and Amortization | 483.60K | 565.80K | 528.60K | 531.30K | 534.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 374.20K | 13.28M | 203.10K | 146.90K | 155.80K |
| Change in Net Operating Assets | -71.80K | -2.10M | 1.04M | 2.51M | -383.50K |
| Cash from Operations | -1.97M | -3.79M | -1.10M | -323.70K | -2.17M |
| Capital Expenditure | -- | -700.00 | -8.10K | 0.00 | -25.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 1.34M | -- | -- | 212.10K |
| Cash from Investing | -- | 1.34M | -8.10K | 0.00 | 186.90K |
| Total Debt Issued | 1.75M | 5.00M | 300.00K | 400.00K | -- |
| Total Debt Repaid | -158.00K | -17.00K | -2.60M | -86.00K | -341.00K |
| Issuance of Common Stock | -- | 0.00 | 3.31M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.11M | 3.56M | 744.90K | 229.50K | -252.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -863.30K | 1.11M | -359.30K | -94.30K | -2.23M |